1	Fill	fill	VB	pb=fill.03	0	root	_
2	out	out	RP	_	1	prt	1:C-V
3	my	my	PRP$	_	5	poss	_
4	online	online	JJ	_	5	amod	_
5	form	form	NN	_	1	dobj	1:A1=GOL
6	.	.	.	_	1	punct	_

1	LONDON	london	NNP	_	2	nsubj	2:A0
2			VBD	p2=:|pb=.01	9	ccomp	_
3	The	the	DT	_	4	det	_
4	board	board	NN	_	2	dobj	2:A1
5	of	of	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	on	on	IN	_	2	prep	2:AM-TMP
8	Monday	monday	NNP	_	7	pobj	_
9	rejected	reject	VBD	pb=reject.01	0	root	_
10	the	the	DT	_	16	det	_
11	improved	improved	JJ	p2=VBN	16	amod	_
12	$	$	$	_	14	quantmod	_
13	119	0	CD	_	14	number	_
14	billion	#crd#	CD	_	16	nn	_
15	takeover	takeover	NN	p2=WDT	16	nn	_
16	offer	offer	NN	p2=VBP	9	dobj	9:A1=PPT
17	from	from	IN	_	16	prep	_
18	U.S.	u.s.	NNP	_	20	nn	_
19	drugmaker	drugmaker	NN	p2=NNP	20	nn	_
20	Pfizer	pfizer	NNP	p2=NN	17	pobj	_
21	,	,	,	_	20	punct	_
22	a	a	DT	_	23	det	_
23	decision	decision	NN	_	20	appos	25:A0=CAU
24	that	that	WDT	_	25	nsubj	25:R-A0
25	caused	cause	VBD	pb=cause.01	23	rcmod	_
26	a	a	DT	_	28	det	_
27	sharp	sharp	JJ	_	28	amod	_
28	slide	slide	NN	_	25	dobj	25:A1=PPT
29	in	in	IN	_	28	prep	_
30	the	the	DT	_	34	det	_
31	U.K.	u.k.	NNP	_	32	nn	_
32	companys	companys	NNP	p2=POS	34	nn	_
33	share	share	NN	p2=VBP	34	nn	_
34	price	price	NN	_	29	pobj	_
35	as	as	IN	_	38	mark	_
36	many	many	JJ	_	37	amod	_
37	investors	investor	NNS	_	38	nsubj	38:A0
38	think	think	VBP	pb=think.01	25	advcl	25:AM-ADV
39	it	it	PRP	_	41	nsubj	41:A0=PAG
40	effectively	effectively	RB	_	41	advmod	41:AM-MNR
41	brings	bring	VBZ	pb=bring.01	38	ccomp	38:A1=PPT
42	an	an	DT	_	43	det	_
43	end	end	NN	_	41	dobj	41:A1=PPT
44	to	to	IN	_	43	prep	_
45	the	the	DT	_	51	det	_
46	protracted	protract	VBN	p2=JJ|pb=protract.01	51	amod	_
47	and	and	CC	_	46	cc	_
48	increasingly	increasingly	RB	_	49	advmod	_
49	bitter	bitter	JJ	_	46	conj	_
50	takeover	takeover	NN	_	51	nn	_
51	saga	saga	NN	_	44	pobj	46:A1=PPT
52	.	.	.	_	9	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nn	_
2	Inc	inc	NNP	_	0	root	_
3	.	.	.	_	2	punct	_

1	,	,	,	_	3	punct	_
2	which	which	WDT	_	3	nsubj	3:R-A1
3	is	be	VBZ	pb=be.01	0	root	_
4	the	the	DT	_	9	det	_
5	worlds	worlds	JJ	p2=``	9	amod	_
6	second	#ord#	RB	p2=JJ	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	biggest	big	JJS	p2=RBS	9	amod	_
9	drugmaker	drugmaker	NN	_	3	attr	3:A2=PRD
10	by	by	IN	_	9	prep	_
11	revenue	revenue	NN	_	10	pobj	_
12	,	,	,	_	3	punct	_
13	has	have	VBZ	_	15	aux	_
14	been	be	VBN	_	15	aux	_
15	courting	court	VBG	pb=court.01	3	conj	_
16	No.	no.	NN	p2=NNP	19	nn	_
17	8	0	CD	_	16	num	_
18	AstraZeneca	astrazeneca	NNP	_	19	nn	_
19	PLC	plc	NNP	_	15	dobj	15:A1=COM
20	since	since	IN	_	15	prep	15:AM-TMP
21	January	january	NNP	_	20	pobj	_
22	,	,	,	_	15	punct	_
23	arguing	argue	VBG	pb=argue.01	15	advcl	15:AM-PRD
24	their	their	PRP$	_	25	poss	_
25	businesses	business	NNS	_	26	nsubj	26:A1=PPT
26	are	be	VBP	pb=be.01	23	ccomp	23:A1=PPT
27	complementary	complementary	JJ	_	26	acomp	26:A2=PRD
28	.	.	.	_	23	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Sunday	sunday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	it	it	PRP	_	5	nsubj	5:A0=PAG
5	raised	raise	VBD	pb=raise.01	0	root	_
6	its	its	PRP$	_	12	poss	_
7	stock	stock	NN	_	12	nn	_
8	-	-	HYPH	_	7	hyph	_
9	and	and	CC	_	7	cc	_
10	-	-	HYPH	_	11	hyph	_
11	cash	cash	NN	_	7	conj	_
12	offer	offer	NN	_	5	dobj	5:A1=PPT
13	by	by	IN	_	5	prep	5:AM-MNR
14	15	0	CD	_	15	num	_
15	percent	percent	NN	_	13	pobj	_
16	to	to	IN	_	5	prep	5:A4=GOL
17	$	$	$	_	19	quantmod	_
18	118.8	0	CD	_	19	number	_
19	billion	#crd#	CD	_	16	pobj	_
20	,	,	,	_	19	punct	_
21	or	or	CC	_	19	cc	_
22	70.73	0	CD	_	23	number	_
23	billion	#crd#	CD	_	24	num	_
24	pounds	pound	NNS	_	19	conj	_
25	.	.	.	_	5	punct	_

1	That	that	DT	_	3	nsubj	3:A1=PPT
2	would	would	MD	_	3	aux	3:AM-MOD
3	be	be	VB	pb=be.01	0	root	_
4	the	the	DT	_	6	det	_
5	richest	rich	JJS	_	6	amod	_
6	acquisition	acquisition	NN	_	3	attr	3:A2=PRD
7	ever	ever	RB	_	6	advmod	_
8	among	among	IN	_	6	prep	_
9	drugmakers	drugmaker	NNS	_	8	pobj	_
10	and	and	CC	_	6	cc	_
11	the	the	DT	_	14	det	_
12	third	#ord#	RB	_	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	biggest	big	JJS	_	6	conj	_
15	in	in	IN	_	14	prep	_
16	any	any	DT	_	17	det	_
17	industry	industry	NN	_	15	pobj	_
18	,	,	,	_	3	punct	_
19	according	accord	VBG	_	3	prep	3:AM-ADV
20	to	to	IN	_	19	prep	_
21	figures	figure	NNS	_	20	pobj	_
22	from	from	IN	_	21	prep	_
23	research	research	NN	_	24	nn	_
24	firm	firm	NN	p2=JJ	25	nn	_
25	Dealogic	dealogic	NNP	_	22	pobj	_
26	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=TO	2	nn	_
2	didnt	didnt	NNP	p2=VBD	3	nsubj	3:A0;6:A0=PAG
3	take	take	VBP	p2=VB|pb=take.01	0	root	_
4	long	long	JJ	p2=RB	3	dobj	3:A1=PPT
5	to	to	TO	_	6	aux	_
6	reject	reject	VB	pb=reject.01	3	advcl	3:AM-PRP
7	the	the	DT	_	9	det	_
8	new	new	JJ	_	9	amod	_
9	offer	offer	NN	_	6	dobj	6:A1=PPT
10	,	,	,	_	9	punct	_
11	its	its	PRP$	_	12	poss	_
12	board	board	NN	_	13	nsubj	13:A0=PAG
13	arguing	argue	VBG	pb=argue.01	9	partmod	_
14	Pfizer	pfizer	NNP	p2=NN	16	nsubj	16:A0=PAG
15	is	be	VBZ	_	16	aux	_
16	making	make	VBG	pb=make.02	13	ccomp	13:A1=PPT
17	an	an	JJ	p2=RBR	19	amod	_
18	opportunistic	opportunistic	JJ	_	19	amod	_
19	attempt	attempt	NN	_	16	dobj	16:AM-PRR
20	to	to	TO	_	21	aux	_
21	acquire	acquire	VB	pb=acquire.01	19	infmod	_
22	a	a	DT	_	24	det	_
23	transformed	transform	VBN	pb=transform.01	24	amod	_
24	AstraZeneca	astrazeneca	NNP	_	21	dobj	21:A1=PPT;23:A1=PPT
25	,	,	,	_	3	punct	_
26	without	without	IN	_	21	prep	21:AM-MNR
27	reflecting	reflect	VBG	pb=reflect.01	26	pcomp	_
28	the	the	DT	_	29	det	_
29	value	value	NN	_	27	dobj	27:A1=PPT
30	of	of	IN	_	29	prep	_
31	its	its	PRP$	_	33	poss	_
32	exciting	exciting	JJ	_	33	amod	_
33	pipeline	pipeline	NN	p2=NNS	30	pobj	_
34	of	of	IN	_	33	prep	_
35	experimental	experimental	JJ	_	36	amod	_
36	drugs	drug	NNS	_	34	pobj	_
37	.	.	.	_	3	punct	_

1	Because	because	IN	_	3	mark	_
2	Pfizer	pfizer	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	28	advcl	_
4	it	it	PRP	_	6	nsubj	6:A0=PAG;11:A0=PAG
5	wont	wont	MD	p2=VBD	6	aux	6:AM-MOD;11:AM-MOD
6	raise	raise	VB	pb=raise.01	3	ccomp	3:A1=PPT
7	its	its	PRP$	_	8	poss	_
8	offer	offer	NN	_	6	dobj	6:A1=PPT
9	again	again	RB	_	6	advmod	6:AM-TMP
10	or	or	CC	_	6	cc	_
11	launch	launch	VB	pb=launch.01	6	conj	_
12	a	a	DT	_	15	det	_
13	hostile	hostile	JJ	_	15	amod	_
14	takeover	takeover	NN	_	15	nn	_
15	bid	bid	NN	p2=VBN	11	dobj	11:A1=PPT
16	over	over	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	heads	head	NNS	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	AstraZenecas	astrazenecas	NNP	p2=NNS	21	nn	_
21	board	board	NN	_	19	pobj	_
22	,	,	,	_	28	punct	_
23	the	the	DT	_	24	det	_
24	prospect	prospect	NN	_	28	nsubj	28:A0=PAG
25	of	of	IN	_	24	prep	_
26	a	a	DT	_	27	det	_
27	deal	deal	NN	_	25	pobj	_
28	looks	look	VBZ	pb=look.02	0	root	_
29	increasingly	increasingly	RB	_	30	advmod	_
30	remote	remote	JJ	_	28	acomp	28:A1=PPT
31	unless	unless	IN	_	34	mark	_
32	AstraZeneca	astrazeneca	NNP	_	33	nn	_
33	shareholders	shareholder	NNS	_	34	nsubj	34:A0=PAG
34	urge	urge	VBP	pb=urge.01	28	advcl	28:AM-ADV
35	a	a	DT	_	36	det	_
36	change	change	NN	_	34	dobj	34:A1=PPT
37	of	of	IN	_	36	prep	_
38	mind	mind	NN	_	37	pobj	_
39	.	.	.	_	28	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0
2	has	have	VBZ	_	3	aux	_
3	said	say	VBN	p2=VBD|pb=say.01	0	root	_
4	it	it	PRP	_	5	nsubj	5:A0
5	hopes	hope	VBZ	p2=NNS|pb=hope.01	3	ccomp	3:A1=PPT
6	AstraZenecas	astrazenecas	NNP	p2=IN	7	nn	_
7	shareholders	shareholder	NNS	_	9	nsubj	9:A0=PAG
8	will	will	MD	_	9	aux	9:AM-MOD
9	push	push	VB	pb=push.02	5	ccomp	5:A1=PPT
10	for	for	IN	_	9	prep	9:A2=PRD
11	a	a	DT	_	12	det	_
12	deal	deal	NN	_	10	pobj	_
13	.	.	.	_	3	punct	_

1	Shareholders	shareholder	NNS	_	4	nsubj	6:A0;4:A1=PPT
2	in	in	IN	_	1	prep	_
3	AstraZeneca	astrazeneca	NNP	_	2	pobj	_
4	seemed	seem	VBD	pb=seem.01	0	root	_
5	to	to	TO	_	6	aux	_
6	think	think	VB	pb=think.01	4	xcomp	4:C-A1
7	a	a	DT	_	8	det	_
8	deal	deal	NN	_	9	nsubj	9:A1=PPT
9	is	be	VBZ	pb=be.01	6	ccomp	6:A1=PPT
10	now	now	RB	_	9	advmod	9:AM-TMP
11	unlikely	unlikely	JJ	_	9	acomp	9:A2=PRD
12	,	,	,	_	9	punct	_
13	with	with	IN	_	9	prep	9:AM-ADV
14	the	the	DT	_	17	det	_
15	companys	companys	JJ	p2=``	17	amod	_
16	share	share	NN	_	17	nn	_
17	price	price	NN	_	18	nsubj	18:A1
18	slumping	slump	VBG	p2=NN|pb=slump.01	13	pcomp	_
19	11	0	CD	_	20	num	_
20	percent	percent	NN	_	18	dobj	_
21	to	to	IN	_	18	prep	18:A2=EXT
22	43.15	0	CD	_	23	num	_
23	pounds	pound	NNS	_	21	pobj	_
24	.	.	.	_	4	punct	_

1	Johansson	johansson	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	his	his	PRP$	_	5	poss	_
4	management	management	NN	_	5	nn	_
5	team	team	NN	_	7	nsubj	7:A0=PAG
6	had	have	VBD	_	7	aux	_
7	told	tell	VBN	p2=VBD|pb=tell.01	2	ccomp	2:A1=PPT
8	Pfizer	pfizer	NNP	_	7	dobj	7:A2=GOL
9	over	over	IN	_	7	prep	7:AM-TMP
10	the	the	DT	_	11	det	_
11	weekend	weekend	NN	_	9	pobj	_
12	that	that	IN	_	15	complm	_
13	it	it	PRP	_	15	nsubj	15:A0=PAG;17:A0
14	would	would	MD	_	15	aux	15:AM-MOD
15	need	need	VB	pb=need.01	7	ccomp	7:A1=PPT
16	to	to	TO	_	17	aux	_
17	see	see	VB	pb=see.01	15	xcomp	15:A1=PPT
18	a	a	DT	_	21	det	_
19	10	0	CD	_	20	num	_
20	percent	percent	NN	_	21	nn	_
21	improvement	improvement	NN	_	17	dobj	17:A1
22	over	over	IN	_	21	prep	_
23	the	the	DT	_	30	det	_
24	53.50	0	CD	_	25	num	_
25	pounds	pound	NNS	_	29	hmod	_
26	-	-	HYPH	_	29	hyph	_
27	per	per	IN	_	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	share	share	NN	_	30	nn	_
30	offer	offer	NN	_	22	pobj	32:A1=PPT
31	that	that	WDT	_	32	nsubj	32:R-A1
32	was	be	VBD	pb=be.01	30	rcmod	_
33	on	on	IN	_	32	prep	32:A2=PRD
34	the	the	DT	_	35	det	_
35	table	table	NN	_	33	pobj	_
36	at	at	IN	_	32	prep	32:AM-TMP
37	that	that	DT	_	38	det	_
38	time	time	NN	_	36	pobj	_
39	.	.	.	_	2	punct	_

1	He	he	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	Pfizers	pfizers	NNP	p2=NNPS	5	nn	_
4	latest	late	JJS	_	5	amod	_
5	offer	offer	NN	p2=VBP	6	nsubj	6:A0
6	represented	represented	VBD	pb=represent.01	2	ccomp	2:A1=PPT
7	only	only	RB	_	9	advmod	_
8	a	a	DT	_	9	det	_
9	minor	minor	NN	p2=JJ	6	dobj	6:A1;12:A1=PPT
10	improvement	improvement	''	p2=NN	9	punct	_
11	that	that	WDT	_	12	nsubj	12:R-A1
12	fell	fall	VBD	pb=fall.01	9	rcmod	_
13	short	short	RB	p2=JJ	12	advmod	12:A4=GOL
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	17	det	_
16	10	0	CD	_	17	num	_
17	percent	percent	NN	_	14	pobj	18:A1=PPT
18	needed	need	VBN	p2=VBD|pb=need.01	17	partmod	_
19	.	.	.	_	2	punct	_

1	Though	though	IN	_	4	mark	_
2	it	it	PRP	_	4	nsubj	4:A0
3	has	have	VBZ	_	4	aux	_
4	said	say	VBN	pb=say.01	12	advcl	12:AM-ADV
5	its	its	PRP$	_	7	poss	_
6	indicative	indicative	JJ	_	7	amod	_
7	offer	offer	NN	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	4	ccomp	4:A1=PPT
9	final	final	JJ	_	8	acomp	8:A2=PRD
10	,	,	,	_	12	punct	_
11	Pfizer	pfizer	NNP	_	12	nsubj	12:A0=PAG
12	has	have	VBZ	pb=have.03	0	root	_
13	,	,	,	_	12	punct	_
14	under	under	IN	_	12	prep	_
15	U.K.	u.k.	NNP	_	17	nn	_
16	takeover	takeover	NN	_	17	nn	_
17	rules	rule	NNS	_	14	pobj	_
18	,	,	,	_	12	punct	_
19	until	until	IN	_	28	mark	_
20	5	0	CD	_	21	num	_
21	p.m.	p.m.	NN	p2=RB	28	nsubj	28:A0
22	local	local	JJ	_	23	amod	_
23	time	time	NN	_	21	appos	_
24	on	on	IN	_	19	prep	_
25	May	may	NNP	_	24	pobj	_
26	26	0	CD	_	25	num	_
27	to	to	TO	_	28	aux	_
28	make	make	VB	pb=make.LV	12	advcl	_
29	a	a	DT	_	31	det	_
30	formal	formal	JJ	_	31	amod	_
31	bid	bid	NN	_	28	dobj	28:AM-PRR
32	.	.	.	_	12	punct	_

1	If	if	IN	_	3	mark	_
2	it	it	PRP	_	3	nsubj	3:A0
3	doesnt	doesnt	VBZ	p2=RB|pb=doesnt.01	8	advcl	8:AM-ADV
4	,	,	,	_	8	punct	_
5	it	it	PRP	_	8	nsubj	8:A0
6	can	can	MD	_	8	aux	8:AM-MOD
7	not	not	RB	_	8	neg	8:AM-NEG
8	make	make	VB	pb=make.LV	0	root	_
9	another	another	DT	_	10	det	_
10	offer	offer	NN	_	8	dobj	8:AM-PRR
11	for	for	IN	_	8	prep	8:AM-TMP
12	six	#crd#	CD	_	13	num	_
13	months	month	NNS	_	11	pobj	_
14	.	.	.	_	8	punct	_

1	Pfizers	pfizers	NNS	p2=NNPS	2	nsubj	2:A0=PAG
2	offer	offer	VBP	p2=NN|pb=offer.01	0	root	_
3	comes	come	VBZ	p2=NNS|pb=come.04	0	root	_
4	amid	amid	IN	_	3	prep	3:AM-TMP
5	a	a	DT	_	6	det	_
6	surge	surge	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	other	other	JJ	_	9	amod	_
9	deals	deal	NNS	_	7	pobj	_
10	as	as	IN	p2=RB	12	mark	_
11	drugmakers	drugmaker	NNS	_	12	nsubj	12:A0=PPT
12	look	look	VBP	pb=look.01	3	advcl	3:AM-TMP
13	to	to	IN	p2=TO	12	prep	12:A1=GOL
14	either	either	CC	p2=DT	15	preconj	_
15	grow	grow	VB	p2=VBP	13	pobj	_
16	or	or	CC	_	15	cc	_
17	eliminate	eliminate	VB	pb=eliminate.01	15	conj	_
18	noncore	noncore	JJ	p2=NN	19	amod	_
19	assets	asset	NNS	_	17	dobj	17:A1=PPT
20	to	to	TO	_	21	aux	_
21	focus	focus	VB	pb=focus.01	17	advcl	_
22	on	on	IN	_	21	prep	21:A2=PPT
23	their	their	PRP$	_	24	poss	_
24	strengths	strength	NNS	_	22	pobj	_
25	.	.	.	_	3	punct	_

1	Those	those	DT	_	2	det	_
2	deals	deal	NNS	_	3	nsubj	3:A2=GOL
3	include	include	VBP	pb=include.01	0	root	_
4	Switzerlands	switzerlands	NNP	p2=NNPS	6	nn	_
5	Novartis	novartis	NNP	_	6	nn	_
6	AG	ag	NNP	_	3	dobj	7:A0=PAG;9:A0=PAG;3:A1=PPT
7	agreeing	agree	VBG	pb=agree.01	6	partmod	_
8	to	to	TO	_	9	aux	_
9	buy	buy	VB	pb=buy.01	7	xcomp	7:A1=PPT
10	GlaxoSmithKlines	glaxosmithklines	NNP	p2=JJ	14	nn	_
11	cancer	cancer	NN	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	drug	drug	NN	_	14	nn	_
14	business	business	NN	_	9	dobj	9:A1=PPT
15	for	for	IN	_	9	prep	9:A3=VSP
16	up	up	IN	_	20	quantmod	_
17	to	to	TO	_	20	quantmod	_
18	$	$	$	_	20	quantmod	_
19	16	0	CD	_	20	number	_
20	billion	#crd#	CD	_	15	pobj	_
21	,	,	,	_	6	punct	_
22	to	to	TO	_	23	aux	_
23	sell	sell	VB	pb=sell.01	6	infmod	_
24	most	most	JJS	_	23	dobj	23:A1=PPT
25	of	of	IN	_	24	prep	_
26	its	its	PRP$	_	28	poss	_
27	vaccines	vaccine	NNS	_	28	nn	_
28	business	business	NN	_	25	pobj	_
29	to	to	TO	p2=IN	30	aux	_
30	GSK	gsk	VB	p2=NNP|pb=gsk.01	23	advcl	_
31	for	for	IN	_	30	prep	30:A3
32	$	$	$	_	34	quantmod	_
33	7.1	0	CD	_	34	number	_
34	billion	#crd#	CD	_	31	pobj	_
35	,	,	,	_	6	punct	_
36	plus	plus	CC	_	6	cc	_
37	royalties	royalty	NNS	_	6	conj	_
38	,	,	,	_	3	punct	_
39	and	and	CC	_	3	cc	_
40	to	to	TO	_	41	aux	_
41	sell	sell	VB	pb=sell.01	3	advcl	_
42	its	its	PRP$	_	45	poss	_
43	animal	animal	NN	p2=JJ	45	nn	_
44	health	health	NN	_	45	nn	_
45	division	division	NN	_	41	dobj	41:A1=PPT
46	to	to	IN	_	41	prep	41:A2=GOL
47	Eli	eli	NNP	_	48	nn	_
48	Lilly	lilly	NNP	_	46	pobj	_
49	and	and	CC	_	48	cc	_
50	Co.	co.	NNP	_	48	conj	_
51	of	of	IN	_	48	prep	_
52	Indianapolis	indianapolis	NNP	_	51	pobj	_
53	for	for	IN	_	41	prep	41:A3=VSP
54	about	about	RB	p2=IN	57	advmod	_
55	$	$	$	_	57	quantmod	_
56	5.4	0	CD	_	57	number	_
57	billion	#crd#	CD	_	53	pobj	_
58	.	.	.	_	3	punct	_

1	Canadas	canadas	NNPS	p2=NNP	3	nn	_
2	Valeant	valeant	NNP	_	3	nn	_
3	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	6	nsubj	6:A0
4	has	have	VBZ	_	6	aux	_
5	also	also	RB	_	6	advmod	6:AM-ADV
6	made	make	VBN	pb=make.LV	0	root	_
7	an	an	DT	_	9	det	_
8	unsolicited	unsolicited	JJ	_	9	amod	_
9	offer	offer	NN	_	6	dobj	6:AM-PRR
10	of	of	IN	_	9	prep	_
11	nearly	nearly	RB	_	14	advmod	_
12	$	$	$	_	14	quantmod	_
13	46	0	CD	_	14	number	_
14	billion	#crd#	CD	_	10	pobj	_
15	for	for	IN	_	9	prep	_
16	Botox	botox	NNP	p2=NN	17	nn	_
17	maker	maker	NN	_	18	nn	_
18	Allergan	allergan	NNP	_	15	pobj	22:A0
19	,	,	,	_	18	punct	_
20	which	which	WDT	_	22	nsubj	22:R-A0
21	has	have	VBZ	_	22	aux	_
22	turned	turn	VBN	pb=turn.05	18	rcmod	_
23	it	it	PRP	_	22	dobj	22:A1=PPT
24	down	down	RP	_	22	prt	22:C-V
25	,	,	,	_	18	punct	_
26	so	so	RB	_	27	advmod	_
27	far	far	RB	_	22	advmod	22:AM-TMP
28	.	.	.	_	6	punct	_

1	Pfizers	pfizers	NNS	p2=NNPS	3	nn	_
2	latest	late	JJS	p2=RB	3	amod	_
3	offer	offer	NN	p2=VBP	4	nsubj	4:A0=PAG
4	increased	increase	VBD	pb=increase.01	0	root	_
5	the	the	DT	_	6	det	_
6	ratio	ratio	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	cash	cash	NN	_	10	nn	_
9	AstraZeneca	astrazeneca	NNP	p2=NN	10	nn	_
10	shareholders	shareholder	NNS	_	7	pobj	_
11	would	would	MD	_	12	aux	12:AM-MOD
12	receive	receive	VB	pb=receive.01	4	advcl	_
13	,	,	,	_	12	punct	_
14	from	from	IN	_	12	prep	12:A3
15	33	0	CD	_	16	num	_
16	percent	percent	NN	_	14	pobj	_
17	to	to	IN	_	14	prep	_
18	45	0	CD	_	19	num	_
19	percent	percent	NN	_	17	pobj	_
20	.	.	.	_	4	punct	_

1	The	the	DT	_	3	det	_
2	latest	late	JJS	_	3	amod	_
3	offer	offer	NN	p2=VBP	5	nsubj	5:A0=PAG
4	would	would	MD	_	5	aux	5:AM-MOD
5	give	give	VB	pb=give.01	0	root	_
6	them	them	PRP	_	5	iobj	5:A2=GOL
7	the	the	DT	_	8	det	_
8	equivalent	equivalent	NN	_	5	dobj	5:A1=PPT;17:A1=PPT
9	of	of	IN	_	8	prep	_
10	55	0	CD	_	11	num	_
11	pounds	pound	NNS	_	9	pobj	_
12	for	for	IN	_	8	prep	_
13	each	each	DT	_	15	det	_
14	AstraZeneca	astrazeneca	NNP	_	15	nn	_
15	share	share	NN	p2=VBP	12	pobj	_
16	,	,	,	_	8	punct	_
17	split	split	VBN	p2=VBD|pb=split.01	8	partmod	_
18	between	between	IN	_	17	prep	17:A2=PPT
19	1.747	0	CD	_	20	num	_
20	shares	share	NNS	_	18	pobj	_
21	of	of	IN	_	20	prep	_
22	the	the	DT	_	24	det	_
23	new	new	JJ	_	24	amod	_
24	company	company	NN	_	21	pobj	_
25	and	and	CC	_	20	cc	_
26	2.476	0	CD	_	27	num	_
27	pence	penny	NNS	p2=NN	20	conj	_
28	in	in	IN	_	27	prep	_
29	cash	cash	NN	_	28	pobj	_
30	.	.	.	_	5	punct	_

1	It	it	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	the	the	DT	_	4	det	_
4	offer	offer	NN	_	5	nsubj	5:A0=PAG
5	represents	represent	VBZ	pb=represent.01	2	ccomp	2:A1=PPT
6	a	a	DT	_	9	det	_
7	45	0	CD	_	8	num	_
8	percent	percent	NN	_	9	nn	_
9	premium	premium	NN	_	5	dobj	5:A1=PPT
10	to	to	IN	p2=TO	5	prep	_
11	AstraZenecas	astrazenecas	NNP	p2=JJ	13	nn	_
12	share	share	NN	p2=VBP	13	nn	_
13	price	price	NN	_	10	pobj	_
14	of	of	IN	_	13	prep	_
15	37.82	0	CD	_	16	num	_
16	pounds	pound	NNS	_	14	pobj	_
17	on	on	IN	_	13	prep	_
18	April	april	NNP	_	17	pobj	_
19	17	0	CD	_	18	num	_
20	,	,	,	_	5	punct	_
21	before	before	IN	_	26	mark	_
22	rumors	rumor	NNS	_	26	nsubj	26:A1=PPT;27:A1=PPT
23	of	of	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	deal	deal	NN	_	23	pobj	_
26	began	begin	VBD	pb=begin.01	5	advcl	_
27	circulating	circulate	VBG	pb=circulate.01	26	xcomp	26:C-A1
28	.	.	.	_	2	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	insisted	insist	VBN	pb=insist.01	0	root	_
4	Pfizers	pfizers	NNP	p2=NNPS	5	nsubj	5:A0=PAG
5	offers	offer	VBZ	p2=NNS|pb=offer.01	3	ccomp	3:A1=PPT
6	significantly	significantly	RB	_	7	advmod	_
7	undervalue	undervalue	IN	p2=VB	5	prep	5:A3=GOL
8	the	the	DT	_	9	det	_
9	company	company	NN	_	7	pobj	_
10	and	and	CC	_	9	cc	_
11	its	its	PRP$	_	12	poss	_
12	portfolio	portfolio	NN	_	9	conj	_
13	of	of	IN	_	12	prep	_
14	experimental	experimental	JJ	_	15	amod	_
15	drugs	drug	NNS	_	13	pobj	_
16	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	9	nsubj	9:A0=PAG
3	and	and	CC	_	2	cc	_
4	British	british	JJ	_	6	amod	_
5	government	government	NN	_	6	nn	_
6	officials	official	NNS	_	2	conj	_
7	also	also	RB	_	9	advmod	9:AM-DIS
8	have	have	VBP	_	9	aux	_
9	raised	raise	VBN	pb=raise.01	0	root	_
10	concerns	concern	NNS	_	9	dobj	9:A1=PPT
11	about	about	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	prospect	prospect	NN	_	11	pobj	_
14	of	of	IN	_	13	prep	_
15	job	job	NN	_	16	nn	_
16	cuts	cut	NNS	_	14	pobj	_
17	,	,	,	_	16	punct	_
18	facility	facility	NN	_	19	nn	_
19	closures	closure	NNS	_	16	conj	_
20	and	and	CC	_	19	cc	_
21	losing	lose	VBG	pb=lose.02	19	conj	_
22	some	some	DT	_	21	dobj	21:A1=PPT
23	of	of	IN	_	22	prep	_
24	the	the	DT	_	26	det	_
25	science	science	NN	_	26	nn	_
26	leadership	leadership	NN	_	23	pobj	_
27	in	in	IN	_	26	prep	_
28	the	the	DT	_	29	det	_
29	U.K.	u.k.	NNP	_	27	pobj	36:AM-LOC
30	,	,	,	_	29	punct	_
31	where	where	WRB	_	36	advmod	36:R-AM-LOC
32	London	london	NNP	_	34	hmod	_
33	-	-	HYPH	_	34	hyph	_
34	based	base	VBN	_	35	amod	_
35	AstraZeneca	astrazeneca	NNP	_	36	nsubj	36:A1=PPT
36	is	be	VBZ	pb=be.01	29	rcmod	_
37	the	the	DT	_	41	det	_
38	second	#ord#	RB	_	40	hmod	_
39	-	-	HYPH	_	40	hyph	_
40	biggest	big	JJS	p2=RBS	41	amod	_
41	drugmaker	drugmaker	NN	_	36	attr	36:A2=PRD
42	,	,	,	_	41	punct	_
43	behind	behind	IN	p2=RB	36	prep	_
44	GlaxoSmithKline	glaxosmithkline	NNP	_	45	nn	_
45	PLC	plc	NNP	_	43	pobj	_
46	.	.	.	_	9	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0
2	has	have	VBZ	_	3	aux	_
3	assured	assure	VBN	pb=assure.01	0	root	_
4	such	such	JJ	_	5	amod	_
5	cuts	cut	NNS	_	3	dobj	3:A1=GOL;7:A1=PPT
6	would	would	MD	_	7	aux	7:AM-MOD
7	be	be	VB	pb=be.01	3	ccomp	3:A2=PPT
8	limited	limited	JJ	p2=VBN	7	acomp	7:A2=PRD
9	.	.	.	_	3	punct	_

1	Its	its	NNP	p2=NNS	2	nsubj	2:A0=PAG;4:A0=PAG
2	promised	promise	VBD	pb=promise.01	0	root	_
3	to	to	TO	p2=IN	4	aux	_
4	complete	complete	VB	p2=JJ|pb=complete.01	2	xcomp	2:A2=PPT
5	AstraZenecas	astrazenecas	NNP	p2=NNPS	9	nn	_
6	research	research	NN	p2=VB	9	nn	_
7	and	and	CC	_	6	cc	_
8	development	development	NN	_	6	conj	_
9	hub	hub	NN	_	4	dobj	4:A1=PPT
10	in	in	IN	_	4	prep	_
11	Cambridge	cambridge	NNP	_	10	pobj	_
12	.	.	.	_	2	punct	_

1	And	and	CC	_	3	cc	3:AM-DIS
2	it	it	PRP	_	3	nsubj	3:A0=PAG;5:A0
3	pledged	pledge	VBD	pb=pledge.01	0	root	_
4	to	to	TO	_	5	aux	_
5	establish	establish	VB	pb=establish.01	3	xcomp	3:A2=PPT
6	the	the	DT	_	10	det	_
7	new	new	JJ	_	10	amod	_
8	companys	companys	JJ	p2=NNS	10	amod	_
9	tax	tax	NN	_	10	nn	_
10	residence	residence	NN	_	5	dobj	5:A1=PPT
11	,	,	,	_	5	punct	_
12	but	but	CC	_	8	cc	_
13	not	not	RB	_	14	neg	_
14	headquarters	headquarter	NNS	p2=NN	5	conj	22:A0
15	,	,	,	_	14	punct	_
16	in	in	IN	_	14	prep	_
17	England	england	NNP	_	16	pobj	_
18	,	,	,	_	14	punct	_
19	which	which	WDT	_	22	nsubj	22:R-A0
20	would	would	MD	_	22	aux	22:AM-MOD
21	significantly	significantly	RB	_	22	advmod	22:A2=EXT
22	reduce	reduce	VB	pb=reduce.01	14	rcmod	_
23	its	its	PRP$	_	26	poss	_
24	future	future	JJ	p2=NN	26	amod	_
25	tax	tax	NN	_	26	nn	_
26	rate	rate	NN	_	22	dobj	22:A1=PPT
27	.	.	.	_	3	punct	_

1	But	but	CC	_	4	cc	4:AM-DIS
2	layoffs	layoff	NNS	_	4	nsubj	4:A1=PPT
3	would	would	MD	_	4	aux	4:AM-MOD
4	be	be	VB	pb=be.01	13	ccomp	13:A1=PPT
5	inevitable	inevitable	JJ	_	4	acomp	4:A2=PRD
6	in	in	IN	_	4	prep	4:AM-LOC
7	such	such	PDT	_	10	predet	_
8	a	a	DT	_	10	det	_
9	big	big	JJ	_	10	amod	_
10	merger	merger	NN	_	6	pobj	_
11	,	,	,	_	13	punct	_
12	analysts	analyst	NNS	_	13	nsubj	13:A0
13	say	say	VBP	pb=say.01	0	root	_
14	,	,	,	_	13	punct	_
15	and	and	CC	_	13	cc	_
16	Pfizer	pfizer	NNP	_	17	nsubj	17:A0=PAG;22:A0=PAG
17	has	have	VBZ	pb=have.03	13	conj	_
18	a	a	DT	_	20	det	_
19	track	track	NN	_	20	nn	_
20	record	record	NN	_	17	dobj	17:A1=PPT
21	of	of	IN	_	20	prep	_
22	eliminating	eliminate	VBG	pb=eliminate.01	21	pcomp	_
23	tens	#crd#	NNS	_	22	dobj	22:A1=PPT
24	of	of	IN	_	23	prep	_
25	thousands	#crd#	NNS	_	24	pobj	_
26	of	of	IN	_	25	prep	_
27	jobs	job	NNS	_	26	pobj	_
28	as	as	IN	_	27	prep	_
29	a	a	DT	_	30	det	_
30	result	result	NN	_	28	pobj	_
31	of	of	IN	_	30	prep	_
32	megadeals	megadeal	NNS	_	31	pobj	_
33	.	.	.	_	17	punct	_

1	While	while	IN	_	5	mark	_
2	Pfizer	pfizer	NNP	_	5	nsubjpass	_
3	is	be	VBZ	_	5	auxpass	_
4	best	well	RBS	p2=RB	5	advmod	_
5	known	known	JJ	p2=VBN	42	advcl	_
6	to	to	IN	_	5	prep	_
7	the	the	DT	_	8	det	_
8	public	public	NN	p2=JJ	6	pobj	_
9	for	for	IN	_	5	prep	_
10	Viagra	viagra	NNP	p2=NN	9	pobj	_
11	,	,	,	_	10	punct	_
12	cholesterol	cholesterol	NN	_	13	nn	_
13	fighter	fighter	NN	_	14	nn	_
14	Lipitor	lipitor	NNP	p2=NN	10	conj	_
15	and	and	CC	_	14	cc	_
16	other	other	JJ	_	19	amod	_
17	widely	widely	RB	_	18	advmod	18:AM-EXT
18	used	use	VBN	p2=JJ|pb=use.01	19	amod	_
19	medicines	medicine	NNS	_	14	conj	18:A1=PPT
20	,	,	,	_	19	punct	_
21	in	in	IN	_	0	root	_
22	the	the	DT	_	25	det	_
23	pharmaceutical	pharmaceutical	JJ	p2=NN	25	amod	_
24	industry	industry	NN	_	25	nn	_
25	its	its	NNS	p2=PRP$	21	pobj	26:A1=PPT
26	known	know	VBN	pb=know.01	25	partmod	_
27	for	for	IN	_	26	prep	26:A2=PRD
28	two	#crd#	CD	_	30	num	_
29	other	other	JJ	_	30	amod	_
30	things	thing	NNS	_	27	pobj	42:A0
31	:	:	:	_	30	punct	_
32	marketing	marketing	NN	p2=VBG	33	nn	_
33	muscle	muscle	NN	_	30	appos	_
34	and	and	CC	_	33	cc	_
35	mega	mega	JJ	p2=NN	36	amod	_
36	mergers	merger	NNS	_	33	conj	_
37	,	,	,	_	36	punct	_
38	which	which	WDT	_	42	nsubj	42:R-A0
39	together	together	RB	_	42	advmod	42:AM-MNR
40	have	have	VBP	_	42	aux	_
41	repeatedly	repeatedly	RB	_	42	advmod	42:AM-TMP
42	propelled	propel	VBN	pb=propel.01	30	rcmod	_
43	it	it	PRP	_	42	dobj	42:A1=PPT
44	to	to	IN	_	42	prep	42:A2=GOL
45	the	the	DT	_	46	det	_
46	top	top	NN	_	44	pobj	_
47	.	.	.	_	19	punct	_

1	Since	since	IN	_	6	prep	6:AM-TMP
2	2000	0	CD	_	1	pobj	_
3	,	,	,	_	6	punct	_
4	it	it	PRP	_	6	nsubj	6:A0=PAG
5	has	have	VBZ	_	6	aux	_
6	made	make	VBN	pb=make.02	0	root	_
7	three	#crd#	CD	_	8	num	_
8	acquisitions	acquisition	NNS	_	6	dobj	11:A0=PAG;6:AM-PRR
9	that	that	WDT	_	11	nsubj	11:R-A0;15:R-A0
10	have	have	VBP	_	11	aux	_
11	vaulted	vault	VBN	pb=vault.01	8	rcmod	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	11	dobj	15:A0;11:A1=PPT
14	to	to	TO	p2=IN	15	aux	_
15	No.	no.	VB	p2=$|pb=no..01	11	advcl	11:A3=DIR
16	1	0	CD	_	15	dobj	15:A1
17	in	in	IN	_	15	prep	_
18	revenue	revenue	NN	_	17	pobj	_
19	.	.	.	_	6	punct	_

1	It	it	PRP	_	2	nsubj	2:A0=PAG
2	paid	pay	VBD	pb=pay.01	0	root	_
3	$	$	$	_	5	quantmod	_
4	111.8	0	CD	_	5	number	_
5	billion	#crd#	CD	_	2	dobj	2:A1=VSP
6	for	for	IN	_	2	prep	2:A3=PPT
7	Warner	warner	NNP	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	Lambert	lambert	NNP	_	10	nn	_
10	Co.	co.	NNP	_	6	pobj	_
11	in	in	IN	_	2	prep	2:AM-TMP
12	2000	0	CD	_	11	pobj	_
13	to	to	TO	_	14	aux	_
14	get	get	VB	pb=get.01	2	advcl	_
15	the	the	DT	_	16	det	_
16	rights	right	NNS	_	14	dobj	14:A1=PPT
17	to	to	IN	_	16	prep	_
18	Lipitor	lipitor	NNP	p2=NN	17	pobj	_
19	,	,	,	_	18	punct	_
20	then	then	RB	_	23	advmod	_
21	$	$	$	_	23	quantmod	_
22	59.8	0	CD	_	23	number	_
23	billion	#crd#	CD	_	18	appos	_
24	for	for	IN	_	23	prep	_
25	Pharmacia	pharmacia	NNP	_	26	nn	_
26	Corp	corp	NNP	_	24	pobj	_
27	.	.	.	_	2	punct	_

1	in	in	IN	p2=RP	6	prep	_
2	2003	0	CD	_	1	pobj	_
3	and	and	CC	_	2	cc	_
4	$	$	$	_	6	quantmod	_
5	68	0	CD	_	6	number	_
6	billion	#crd#	CD	_	0	root	_
7	for	for	IN	_	6	prep	_
8	Wyeth	wyeth	NNP	_	7	pobj	_
9	in	in	IN	_	6	prep	_
10	2009	0	CD	_	9	pobj	_
11	,	,	,	_	6	punct	_
12	according	accord	VBG	_	6	prep	_
13	to	to	IN	_	12	prep	_
14	Dealogic	dealogic	NNP	_	13	pobj	_
15	.	.	.	_	1	punct	_

1	With	with	IN	_	8	prep	8:AM-ADV
2	this	this	DT	_	3	det	_
3	deal	deal	NN	_	1	pobj	_
4	,	,	,	_	8	punct	_
5	Pfizer	pfizer	NNP	p2=NN	8	nsubj	8:A1=PPT
6	would	would	MD	_	8	aux	8:AM-MOD
7	then	then	RB	_	8	advmod	8:AM-TMP
8	be	be	VB	pb=be.01	0	root	_
9	the	the	DT	_	10	det	_
10	buyer	buyer	NN	_	8	attr	8:A2=PRD
11	in	in	IN	_	10	prep	_
12	four	#crd#	CD	_	11	pobj	_
13	of	of	IN	_	12	prep	_
14	the	the	DT	_	17	det	_
15	10	0	CD	_	17	num	_
16	richest	rich	JJS	_	17	amod	_
17	deals	deal	NNS	_	13	pobj	_
18	ever	ever	RB	_	17	advmod	_
19	in	in	IN	_	17	prep	_
20	the	the	DT	_	22	det	_
21	pharmaceutical	pharmaceutical	JJ	_	22	amod	_
22	industry	industry	NN	_	19	pobj	_
23	.	.	.	_	8	punct	_

1	Each	each	DT	_	5	nsubj	5:A1=PPT
2	of	of	IN	_	1	prep	_
3	those	those	DT	_	4	det	_
4	deals	deal	NNS	_	2	pobj	_
5	resulted	result	VBD	p2=VBN|pb=result.01	0	root	_
6	in	in	IN	_	5	prep	5:A2=LOC
7	massive	massive	JJ	_	8	amod	_
8	layoffs	layoff	NNS	_	6	pobj	_
9	and	and	CC	_	8	cc	_
10	closures	closure	NNS	_	8	conj	_
11	of	of	IN	_	8	prep	_
12	some	some	DT	_	14	det	_
13	medicine	medicine	NN	p2=JJ	14	nn	_
14	factories	factory	NNS	_	11	pobj	_
15	,	,	,	_	14	punct	_
16	research	research	NN	_	17	nn	_
17	facilities	facility	NNS	_	14	conj	_
18	and	and	CC	_	17	cc	_
19	office	office	NN	_	20	nn	_
20	buildings	building	NNS	_	17	conj	_
21	,	,	,	_	17	punct	_
22	with	with	IN	_	17	prep	_
23	the	the	DT	_	26	det	_
24	cost	cost	NN	_	26	hmod	_
25	-	-	HYPH	p2=,	26	hyph	_
26	cutting	cutting	NN	p2=VBG	27	nsubj	27:A0=PAG
27	boosting	boost	VBG	p2=NN|pb=boost.01	22	pcomp	_
28	Pfizers	pfizers	NNP	p2=NNPS	30	nn	_
29	bottom	bottom	JJ	p2=NN	30	amod	_
30	line	line	NN	_	27	dobj	27:A1=PPT
31	for	for	IN	_	27	prep	27:AM-TMP
32	a	a	DT	_	34	det	_
33	few	few	JJ	_	34	amod	_
34	years	year	NNS	_	31	pobj	_
35	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0=PAG;5:A0=PAG;11:A0=PAG
2	now	now	RB	_	3	advmod	3:AM-TMP
3	wants	want	VBZ	pb=want.01	0	root	_
4	to	to	TO	_	5	aux	_
5	add	add	VB	pb=add.02	3	xcomp	3:A1=PPT
6	to	to	IN	_	5	prep	5:A2=PPT
7	its	its	PRP$	_	9	poss	_
8	medicine	medicine	NN	_	9	nn	_
9	portfolio	portfolio	NN	_	6	pobj	_
10	to	to	TO	_	11	aux	_
11	boost	boost	VB	pb=boost.01	5	advcl	5:AM-PRP
12	revenue	revenue	NN	_	11	dobj	11:A1=PPT
13	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A1=PPT
3	slipped	slip	VBD	pb=slip.01	0	root	_
4	from	from	IN	_	3	prep	3:A3=DIR
5	No.	no.	NN	_	4	pobj	_
6	1	0	CD	_	5	num	_
7	to	to	IN	_	3	prep	3:A4=GOL
8	No.	no.	NN	_	7	pobj	_
9	2	0	CD	_	8	num	_
10	last	last	JJ	_	11	amod	_
11	year	year	NN	_	3	npadvmod	3:AM-TMP
12	,	,	,	_	3	punct	_
13	behind	behind	IN	_	3	prep	_
14	Novartis	novartis	NNP	_	15	nn	_
15	AG	ag	NNP	_	13	pobj	_
16	,	,	,	_	3	punct	_
17	mainly	mainly	RB	_	20	advmod	_
18	because	because	IN	_	20	mark	_
19	Lipitor	lipitor	NNP	p2=NN	20	nsubj	20:A0=PAG;29:A0=PAG
20	got	get	VBD	pb=get.01	3	advcl	_
21	generic	generic	JJ	_	22	amod	_
22	competition	competition	NN	_	20	dobj	20:A1=PPT
23	at	at	IN	_	20	prep	20:AM-TMP
24	the	the	DT	_	25	det	_
25	end	end	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	2011	0	CD	_	26	pobj	_
28	,	,	,	_	20	punct	_
29	wiping	wipe	VBG	pb=wipe.02	20	advcl	20:AM-ADV
30	out	out	RP	_	29	prt	29:C-V
31	several	several	JJ	_	32	amod	_
32	billion	#crd#	CD	_	33	num	_
33	dollars	dollar	NNS	_	29	dobj	29:A1=PPT
34	in	in	IN	_	29	prep	_
35	annual	annual	JJ	_	36	amod	_
36	sales	sale	NNS	_	34	pobj	_
37	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0=PAG;9:A1
2	also	also	RB	_	4	advmod	4:AM-DIS
3	has	have	VBZ	_	4	aux	_
4	sold	sell	VBN	pb=sell.01	28	ccomp	_
5	off	off	RP	_	4	prt	4:C-V
6	some	some	DT	_	7	det	_
7	units	unit	NNS	_	4	dobj	4:A1=PPT
8	and	and	CC	_	4	cc	_
9	reorganized	reorganize	VBN	p2=VBD|pb=reorganize.01	4	conj	_
10	as	as	IN	_	9	prep	_
11	part	part	NN	_	10	pobj	_
12	of	of	IN	_	11	prep	_
13	preparations	preparation	NNS	_	12	pobj	_
14	to	to	TO	_	16	aux	_
15	possibly	possibly	RB	_	16	advmod	16:AM-ADV
16	break	break	VB	pb=break.01	9	advcl	9:AM-PRP
17	off	off	RP	_	16	prt	16:C-V
18	another	another	DT	_	19	det	_
19	part	part	NN	_	16	dobj	16:A1=PPT
20	of	of	IN	_	19	prep	_
21	the	the	DT	_	22	det	_
22	company	company	NN	_	20	pobj	_
23	,	,	,	_	28	punct	_
24	something	something	NN	_	25	nn	_
25	analysts	analyst	NNS	_	28	nsubj	28:A0=PAG
26	have	have	VBP	_	28	aux	_
27	been	be	VBN	_	28	aux	_
28	urging	urge	VBG	pb=urge.01	0	root	_
29	it	it	PRP	_	28	dobj	31:A0=PAG;28:A1=PPT
30	to	to	TO	_	31	aux	_
31	do	do	VB	pb=do.02	28	xcomp	28:A2=PPT
32	.	.	.	_	28	punct	_

1	Share	share	VB	p2=VBP|pb=share.01	5	advcl	_
2	your	your	PRP$	_	3	poss	_
3	comments	comment	NNS	_	1	dobj	1:A1=PPT
4	:	:	:	_	5	punct	_
5	Log	log	VB	pb=log.01	0	root	_
6	in	in	IN	p2=RP	5	prep	5:A1=PPT
7	using	use	VBG	pb=use.01	6	pcomp	_
8	your	your	PRP$	_	10	poss	_
9	HeraldNet	heraldnet	NNP	_	10	nn	_
10	account	account	NN	_	7	dobj	7:A1=PPT
11	or	or	CC	_	10	cc	_
12	your	your	PRP$	_	13	poss	_
13	Facebook	facebook	NNP	p2=NN	10	conj	_
14	,	,	,	_	13	punct	_
15	Twitter	twitter	NNP	p2=VB	13	conj	_
16	or	or	CC	_	15	cc	_
17	Disqus	disqus	NNP	p2=VBZ	18	nn	_
18	profile	profile	NN	p2=VB	15	conj	_
19	.	.	.	_	5	punct	_

1	Comments	comment	NNS	_	6	nsubj	3:A0=PAG;6:A1=PPT
2	that	that	WDT	_	3	nsubj	3:R-A0
3	violate	violate	VBP	pb=violate.01	1	rcmod	_
4	the	the	DT	_	5	det	_
5	rules	rule	NNS	_	3	dobj	3:A1=PPT
6	are	be	VBP	pb=be.01	0	root	_
7	subject	subject	JJ	_	6	acomp	6:A2=PRD
8	to	to	IN	_	7	prep	_
9	removal	removal	NN	_	8	pobj	_
10	.	.	.	_	6	punct	_

1	Please	please	UH	_	2	intj	2:AM-DIS
2	see	see	VB	p2=UH|pb=see.01	0	root	_
3	our	our	PRP$	_	4	poss	_
4	terms	term	NNS	_	2	dobj	2:A1
5	of	of	IN	_	4	prep	_
6	use	use	NN	_	5	pobj	_
7	.	.	.	_	2	punct	_

1	Please	please	UH	p2=VB	2	intj	2:AM-DIS
2	note	note	VB	p2=NN|pb=note.01	0	root	_
3	that	that	IN	_	6	complm	_
4	you	you	PRP	_	6	nsubj	6:A0
5	must	must	MD	_	6	aux	6:AM-MOD
6	verify	verify	VB	pb=verify.01	2	ccomp	2:A1=PPT
7	your	your	PRP$	_	9	poss	_
8	email	email	NN	_	9	nn	_
9	address	address	NN	p2=VB	6	dobj	6:A1=PPT
10	for	for	IN	_	14	mark	_
11	your	your	PRP$	_	12	poss	_
12	comments	comment	NNS	_	14	nsubj	14:A1=PPT
13	to	to	TO	_	14	aux	_
14	appear	appear	VB	pb=appear.01	6	advcl	6:AM-PNC
15	.	.	.	_	2	punct	_

1	Our	our	PRP$	_	4	poss	_
2	new	new	JJ	_	4	amod	_
3	comment	comment	NN	_	4	nn	_
4	system	system	NN	_	7	nsubjpass	7:A1
5	is	be	VBZ	_	7	auxpass	_
6	not	not	RB	_	7	neg	7:AM-NEG
7	supported	support	VBN	pb=support.01	0	root	_
8	in	in	IN	_	7	prep	7:AM-LOC
9	IE	ie	NNP	_	8	pobj	_
10	7	0	CD	_	9	num	_
11	.	.	.	_	7	punct	_

1	Please	please	UH	_	2	intj	2:AM-DIS
2	upgrade	upgrade	VB	pb=upgrade.02	0	root	_
3	your	your	PRP$	_	4	poss	_
4	browser	browser	NN	_	2	dobj	2:A1=PPT
5	here	here	RB	_	2	advmod	2:AM-LOC
6	.	.	.	_	2	punct	_

1	Unlimited	unlimited	JJ	p2=VBD	3	amod	_
2	digital	digital	JJ	_	3	amod	_
3	access	access	NN	_	4	nsubj	4:A1=PPT;10:A1=PPT
4	starting	start	VBG	pb=start.01	0	root	_
5	at	at	IN	_	4	prep	4:AM-LOC
6	99	0	CD	_	7	num	_
7	cents	cent	NNS	_	5	pobj	_
8	,	,	,	_	4	punct	_
9	or	or	CC	_	4	cc	_
10	included	include	VBD	p2=VBN|pb=include.01	4	conj	_
11	with	with	IN	_	10	prep	10:A2=GOL
12	any	any	DT	_	14	det	_
13	print	print	NN	_	14	nn	_
14	subscription	subscription	NN	_	11	pobj	_
15	.	.	.	_	4	punct	_

